natgillin/translations-raw huggingface dataset:
Via del Pozzo 3/A, S. Martino 53035 Monteriggioni (SI) Italy. 
Via del Pozzo 3/A, S. Martino 53035 Monteriggioni (SI) Italija
• if you have a severe infection with a high temperature (over 38°C). 
• če imate hudo okužbo z visoko telesno temperaturo (več kot 38 °C).
Similar trends were observed for seroprotection rates in both studies. 
Podobne trende so opazili tudi pri stopnjah serozaščite v obeh študijah.
Prompt analysis of cumulative safety information, in light of extent of exposure, will be crucial for regulatory decisions and protection of the population to be vaccinated. 
Takojšnje analize kumulativnih podatkov o varnosti, v luči obsega izpostavljenosti, bodo odločilne za regulatorne odločitve in zaščito populacije, ki bo cepljena.
HI results for the two clinical studies revealed lower values than those reported in previous studies. 
Rezultati HI iz obeh kliničnih študij so pokazali nižje vrednosti od tistih, o katerih so poročali v prejšnjih študijah.
In the first few weeks after vaccination with AFLUNOV the results of these tests may not be correct. 
V prvih tednih po cepljenju s cepivom AFLUNOV so lahko rezultati testov napačni.
Vaccination is currently not recommended in this age group. 
Cepljenje pri tej starostni skupini trenutno ni priporočeno.
Dispose of in accordance with local requirements. 
Odstranite v skladu z nacionalnimi zahtevami.
- Italy 
- Italija
Such situation requires rapid notification of safety information that may have the greatest implications for risk-benefit balance in a pandemic. 
Takšne razmere zahtevajo hitro obveščanje o varnostnih informacijah, ki lahko najpomembneje vplivajo na razmerje med koristjo in tveganjem med pandemijo.
Clinical trials in special populations 
Klinična preskušanja pri posebnih populacijah
• if you are having a blood test to look for evidence of infection with certain viruses. 
• če ste imeli krvni pregled zaradi znakov okužbe z nekaterimi virusi.
• Generalised skin reactions including 
• Generalizirana kožna reakcija, vključno s:
Periodic Safety Update Reports (PSURs) 
Redno posodobljena poročila o varnosti zdravila (PSUR)
During a pandemic situation, the frequency of submission of periodic safety update reports specified in Article 24 of Regulation 726/2004/EC will not be adequate for the safety monitoring of a pandemic vaccine for which high levels of exposure are expected within a short period of time. 
Med pandemskimi razmerami pogostnost predložitve poročil o varnosti zdravila, ki je določena v členu 24 Uredbe 726/2004/ES, ne bo zadostovala za spremljanje varnosti pandemičnega cepiva, za katerega se v kratkem času pričakuje visoka stopnja izpostavljenosti.
• Severe stabbing or throbbing pain along one or more nerves 
• močna zbadajoča ali utripajoča bolečina vzdolž enega ali več živcev,
Immunogenicity was assessed in 182 subjects. 
Imunogenost so ocenili pri 182 osebah.
N=145 N=149 N=59 N=58 N=147 N=148 N=58 N=62 
Število preskušancev N = 145 N = 149 N = 59 N = 58 N = 147 N = 148 N = 58 N = 62
Currently available data in subjects aged 6 months to 18 years of age are described in section 5.1 but no recommendation on a posology can be made. 
Trenutno razpoložljivi podatki pri preiskovancih, starih od 6 mesecev do 18 let,so opisani v poglavju 5.1, vendar priporočil o odmerjanju ni mogoče dati.
Doctors are aware of this possibility and have emergency treatment available for use in such cases. 
Zdravniki poznajo to možnost, zato imajo za take primere pripravljeno nujno medicinsko pomoč.
Some of the undesirable effects mentioned under section 4.8 may affect the ability to drive or operate machinery. 
Nekateri neželeni učinki, navedeni v poglavju 4.8, lahko vplivajo na sposobnost vožnje in upravljanja s stroji.
In accordance with Article 114 of Directive 2001/83/EC, the official batch release will be taken by a state laboratory or a laboratory designated for that purpose. 
V skladu s členom 114 Direktive 2001/83/ES z vsemi dopolnitvami in spremembami, serijo uradno sprosti državni laboratorij ali laboratorij, določen v ta namen.
Human infections are primarily caused by contact with infected animals, but do not spread easily between people. 
Ljudje se ponavadi okužijo pri stiku z okuženimi živalmi, okužba pa se med ljudmi ne prenaša zlahka.
There is limited experience in elderly over 70 years of age (see section 5.1). 
Pri starejših od 70 let so izkušnje omejene (glejte poglavje 5.1).
There are no data concerning human fertility. 
Ni podatkov v zvezi s plodnostjo pri človeku.
A minor infection such as a cold should not be a problem, but your doctor or nurse should advise whether you could still be vaccinated with AFLUNOV; 
Blažja okužba kot je prehlad ne predstavlja težave, vendar vam bosta zdravnik ali medicinska sestra svetovala, ali se lahko še vedno cepite s cepivom AFLUNOV,
Healthcare providers need to assess the benefit and potential risks of administering the vaccine to pregnant women taking into consideration official recommendations. 
Zdravstveni delavci morajo oceniti koristi in možna tveganja cepljenja nosečih žensk ob upoštevanju uradnih priporočil.
The percentages of subjects reporting local reactions were higher in the older age groups, mainly due to the higher reports for pain. 
Odstotek oseb, ki so poročale o lokalnih reakcijah, je bil višji v skupini s starejšimi bolniki, pretežno zaradi več poročil o bolečinah.
Read all of this leaflet carefully before you receive this vaccine because it contains important information for you. 
Preden se cepite, natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
A second dose of 0.5 ml should be given after an interval of at least 3 weeks. 
Drugi odmerek 0,5 ml cepiva je treba dati po presledku vsaj 3 tednov.
None of the ingredients in the vaccine can cause flu. 
Nobena sestavina cepiva ne more povzročiti gripe.
In addition, antibody responses in patients with endogenous or iatrogenic immunosuppression may be insufficient to provide protection. 
Poleg tega je protitelesni odziv pri bolnikih z endogeno ali iatrogeno zmanjšanim imunskim odzivom lahko nezadosten za zagotovitev zaščite.
The magnitude of immune response was lower in the group who received the 2nd dose 1 week later and higher in the groups with longer interval schedules. 
Moč imunskega odziva je bila nižja v skupini, ki je prejela 2. odmerek 1 teden kasneje in višja v skupini z daljšimi režimi presledkov.
The suspension is a milky-white liquid. 
Suspenzija je mlečno-bela tekočina.
- Other ingredients: 
- Druge sestavine zdravila:
Available data in paediatric population 
Razpoložljivi podatki za pediatrično populacijo
Pharmacotherapeutic group: Influenza vaccine ATC Code J07BB02. 
Farmakoterapevtska skupina: Cepivo proti gripi, oznaka ATC: J07BB02.
AFLUNOV should be used in accordance with official recommendations. 
Cepivo AFLUNOV je treba uporabljati v skladu z uradnimi priporočili.
In addition, the side effects listed below have occurred in the days or weeks after vaccination with vaccines given routinely every year to prevent seasonal flu. 
Dodatno so se učinki, opisani v nadaljevanju, pojavili v dnevih in tednih po cepljenju s cepivi, ki se rutinsko uporabljajo vsako leto za preprečevanje sezonske gripe.
However, the degree of protection that may be elicited to H5N1 strains of other clades is unknown (see section 5.1). 
Vendar pa stopnja zaščite pred sevi H5N1 iz drugih gruč ni znana (glejte poglavje 5.1).
In consequence, as soon as the pandemic is declared and the zoonotic vaccine is used, the Marketing Authorisation Holder (MAH) shall submit more frequent simplified periodic safety update reports with a format and a periodicity defined in the “CHMP Recommendations for the Core Risk Management Plan for Influenza Vaccines prepared from viruses with the potential to cause a pandemic and intended for use outside of the core dossier context” (EMEA/49993/2008), and any subsequent update. 
Imetnik dovoljenja za promet z zdravilom mora zato takoj po razglasitvi pandemije in uporabi zoonotskega cepiva pogosteje predajati redna poenostavljena posodobljena poročila o varnosti zdravila v obliki in s pogostnostjo, opredeljeni v „CHMP Recommendations for the Core Risk Management Plan for Influenza Vaccines prepared from viruses with the potential to cause a pandemic and intended for use outside of the core dossier context“ (EMEA/49993/2008) in v vseh nadaljnjih dopolnitvah.
It is important that procedures are in place to avoid injury from faints 
Pomembno je, da se postopek opravi na mestu, kjer se je možno izogniti poškodbam zaradi omedlevice.
Any unused vaccine and waste material should be disposed of in accordance with local requirements. 
Neuporabljeno cepivo ali odpadni material zavrzite v skladu z lokalnimi predpisi.
Allergic reactions may occur following vaccination, in rare cases leading to shock. 
Po cepljenju se lahko pojavijo alergijske reakcije, ki v redkih primerih vodijo v šok.
Vaccination protected animals from lethal challenge even when HI antibody titres were low or undetectable. 
Cepljenje je zaščitilo živali pred letalno provokacijo tudi, ko so bili titri protitelesa HI nizki ali nedoločljivi.
• extensive swelling of injected limb lasting more than one week. 
• Obsežna oteklina okončine, v katero je bilo injicirano cepivo, ki traja več kot en teden.
Tell your doctor if you have a weak immune system or an underlying long term medical problem. 
Obvestite zdravnika, če imate oslabljen imunski sistem ali dolgotrajno osnovno bolezensko stanje.
The vaccine should never be given into a vein. 
Cepivo se ne sme nikoli injicirati v veno.
Alternative vaccination schedules: 
Drugi režimi cepljenja:
It should be noted that the adverse reactions may be intensified. 
Opozoriti je treba, da so lahko neželeni učinki izrazitejši.
In addition, duration a pandemic, resources needed for an in-depth evaluation of PSURs in the format as defined in Volume 9a of the Rules Governing Medicinal Product in the European Union may not be adequate for a rapid identification of a new safety issue. 
Poleg tega med trajanjem pandemije viri, potrebni za poglobljeno vrednotenje PSUR v obliki, kot je definirana v Pravilih, ki urejajo zdravila v Evropski skupnosti „Rules Governing Medicinal Product in the European Union - Volume 9a“ morda ne bodo zadostovali za hitro identifikacijo novih varnostnih izsledkov.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before receiving this vaccine. 
Nosečnost in dojenje Če ste noseči ali dojite, menite, da bi lahko bili noseči, ali načrtujete zanositev, se pred cepljenjem s tem cepivom posvetujte z zdravnikom ali medicinsko sestro.
Irrespective of antigen dose, almost all systemic reactions were reported on the day of vaccination (day 1) or during the 3 days immediately following. 
Ne glede na odmerek antigena so o skoraj vseh sistemskih neželenih učinkih poročali na dan cepljenja (1. dan) ali v 3 dneh naslednjih dneh.
Efficacy against challenge with the heterologous virus A/Indonesia/5/2005 was also tested. 
Testirali so tudi učinkovitost proti provokaciji s heterolognim virusom seva A/Indonesia/5/2005.
There is limited experience in elderly over 70 years of age. 
Pri starejših od 70 let so izkušnje omejene.
Therefore, healthcare providers need to assess the benefits and potential risks of administering the vaccine in individuals with thrombocytopenia or any bleeding disorder that would contraindicate intramuscular injection unless the potential benefit outweighs the risk of bleedings. 
Zato morajo zdravstveni delavci oceniti prednosti in možna tveganja, povezana z dajanjem cepiva, pri bolnikih s trombocitopenijo ali motnjami krvavitev, ki kontraindicirajo intramuskularno injiciranje, razen kadar so možne koristi večje od tveganja krvavitev.
There were 3872 subjects 18-60 years of age, 365 subjects 61-70 years of age, and 89 subjects greater than 70 years of age. 
3.872 oseb je bilo starih med 18 in 60 let, 365 oseb med 61 in 70 let in 89 oseb je bilo starejših od 70 let.
These transitory false positive results may be due to IgM production in response to the vaccine. 
Prehodno lažni pozitivni rezultati so lahko posledica nastajanja protiteles IgM kot odziv na cepivo.
Long term booster immune memory: 
Dolgoročni obnovitveni imunski spomin:
AFLUNOV is intended also to be given when there is anticipation of a possible pandemic due to the same or a similar strain. 
Cepivo AFLUNOV je namenjeno za uporabo tudi takrat, ko se pričakuje morebitno pandemijo zaradi seva virusa, podobnega ali enakega cepilnemu sevu.
Consistent with the data observed by trial for solicited reactions, there was a general trend towards decreased reports of local reactions after the second vaccination compared with the first injection. 
Skladno s podatki, ki so jih opazili v preskušanjih pričakovanih neželenih učinkov, je splošni trend kazal upad poročil za lokalne neželene učinke po drugem cepljenju v primerjavi s prvo injekcijo.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V. 
Od zdravstvenih delavcev se zahteva, da poročajo o katerem koli domnevnem neželenem učinku cepiva na nacionalni center za poročanje, ki je naveden v Prilogi V.
MN results yielded a GMR against A/turkey/Turkey/2005 ranging from 1.59 to 2.95. 
Rezultati MN so pokazali GMR proti sevu A/turkey/Turkey/2005 v razponu od 1,59 do 2,95.
Reporting suspected adverse reactions after authorisation of the medicinal product is important. 
Poročanje o domnevnih neželenih učinkih cepiva po izdaji dovoljenja za promet je pomembno.
Viral shedding and viral titres in lungs were also reduced, suggesting that vaccination may reduce the risk of viral transmission. 
Zmanjšali so se tudi razmnoževanje virusa in titri virusa v pljučih, kar kaže, da lahko cepivo zmanjša tveganje prenosa virusa.
Regardless of age, reactogencity was higher after the first dose than after the second vaccination. 
Ne glede na starost je bila reaktogenost višja po prvem kot po drugem odmerku cepljenja.
Adjuvant: MF59C.1 oil in water emulsion containing squalene, as the oil phase, stabilised with polysorbate 80 and sorbitan trioleate. 
Adjuvans: emulzija olje v vodi MF59C.1, ki vsebuje skvalen kot oljno fazo, stabilizirana s polisorbatom 80 in sorbitantrioleatom.
In addition, vomiting was commonly reported. 
Poleg tega so pogosto poročali o bruhanju.
The majority of these side effects usually disappear within 1-2 days without treatment. 
Večina teh neželenih učinkov običajno izzveni v 1-2 dneh brez zdravljenja.
Zoonotic influenza viruses occasionally infect humans, and can cause disease ranging from mild upper respiratory infection (fever and cough) to rapid progression to severe pneumonia, acute respiratory distress syndrome, shock and even death. 
Zoonotski virusi gripe včasih okužijo ljudi in lahko povzročijo vse od blage okužbe zgornjih dihal (vročino in kašelj) pa do zelo hitro napredujoče bolezni, ki vodi v hudo pljučnico, akutno dihalno stisko, šok in celo smrt.
Immunogenicity was assessed in a subset (n=197) of subjects . 
Imunogenosti so ocenili v podskupini (N = 197) oseb.
Following influenza vaccination, false positive serology test results may be obtained by the ELISA method for antibody to human immunodeficiency virus-1 (HIV-1), hepatitis C virus and, especially, human T-lymphotropic virus type 1 (HTLV-1). 
Po cepljenju proti gripi so poročali o lažno pozitivnih rezultatih seroloških testov z metodo ELISA za odkrivanje protiteles proti virusu humane imunske pomanjkljivosti 1 (HIV-1), virusu hepatitis C in zlasti proti humanemu T-celičnemu limfotropnemu virusu tipa 1 (HTLV-1).
In any of these cases, TELL YOUR DOCTOR OR NURSE, as vaccination may not be recommended, or may need to be delayed. 
V vseh zgoraj naštetih primerih OBVESTITE ZDRAVNIKA ALI MEDICINSKO SESTRO, saj morda cepljenje ni priporočljivo ali ga je treba preložiti na kasneje.
Ferrets received one or two doses of vaccine (A/Vietnam/1194/2004). 
Beli dihurji so prejeli enega ali dva odmerka cepiva (A/Vietnam/1194/2004).
• Flu like symptoms 
• gripi podobni simptomi,
For the adjuvant, see section 2 
Za adjuvans glejte poglavje 2.
If this applies to you then your vaccination will usually be postponed until you are feeling better. 
V tem primeru bo zdravnik cepljenje verjetno preložil na kasneje, ko se boste počutili bolje.
It is provided in a ready-to-use pre-filled syringe, containing a single dose of 0.5 ml for injection. 
Na voljo je v pripravljeni napolnjeni injekcijski brizgi, ki vsebuje en odmerek 0,5 ml za injiciranje.
Two doses of vaccine protected 92% of animals, and a single dose of vaccine protected 50% of animals against challenge with the A/Indonesia/5/2005 virus. 
Dva odmerka cepiva sta zaščitila 92 % živali, medtem ko je en odmerek cepiva zaščitil 50 % živali pred provokacijo z virusom A/Indonesia/5/2005.
Tell your doctor or nurse if you are taking or have recently taken or might take any other medicines, including medicines obtained without a prescription or have recently received any other vaccine. 
Obvestite zdravnika ali medicinsko sestro, če jemljete, ste pred kratkim jemali ali boste morda začeli jemati katero koli drugo zdravilo, tudi če ste ga dobili brez recepta, ali če ste bili cepljeni z drugim cepivom.
Compared to the antibody levels obtained at day 43 after completion of primary vaccination schedules, antibody levels at day 202 were reduced by 1/5 to 1/2 from their prior levels. 
V primerjavi z ravnmi protiteles, pridobljenimi 43. dan po zaključku primarnega režima cepljenja, so bile ravni protiteles 202. dan zmanjšane za 1/5 do 1/2 glede na predhodne ravni.
MN results, similar to SRH results, demonstrated strong immune response after completion of priming vaccination series in a population of elderly subjects. 
Podobno kot rezultati SRH kažejo tudi rezultati MN močan imunski odgovor po končani seriji primarnega cepljenja v populaciji starejših oseb.
“Possible side effects” may affect the ability to drive or use machines. 
„Možni neželeni učinki“, lahko vplivajo na sposobnost vožnje in upravljanja s stroji.
Animals received one or two doses of vaccine containing 3.75 or 7.5 micrograms of antigen, followed by challenge with a lethal dose of A/Vietnam/1203/04 virus. 
Živali so prejele enega ali dva odmerka cepiva, ki je vsebovalo 3,75 ali 7,5 mikrograma antigena, čemur je sledila provokacija z letalnim odmerkom virusa A/Vietnam/1203/04.
These side effects usually disappear within 1-2 days without treatment. 
Ti neželeni učinki običajno izzvenijo v 1-2 dneh brez zdravljenja.
Do not use AFLUNOV after the expiry date which is stated on the carton and the label. 
Cepiva AFLUNOV ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in nalepki.
* propagated in fertilised hens' eggs from healthy chicken flocks ** expressed in microgram haemagglutinin. 
* namnožen v oplojenih kokošjih jajcih iz jat zdravih piščancev ** izraženo v mikrogramih hemaglutinina
The following solicited adverse reactions were additionally collected in these two studies and reported with the following frequencies across subjects who received AFLUNOV irrespective of age or health status: diarrhoea (up to 11.9%), loss of appetite (up to 10.9%) and vomiting (up to 1.7%). 
V okviru sistematičnega poročanja so v teh dveh študijah zabeležili tudi naslednje neželene učinke, ki so imeli naslednje pogostnosti pri vseh skupinah oseb, udeleženih v študijah, ki so prejele cepivo AFLUNOV, ne glede na starost ali zdravstveno stanje: driska (do 11,9 %), izguba apetita (do 10,9 %) in bruhanje (do 1,7 %).
EU/1/10/658/001 1 prefilled syringe EU/1/10/658/002 10 prefilled syringes 
EU/1/10/658/001 1 napolnjena injekcijska brizga EU/1/10/658/002 10 napolnjenih injekcijskih brizg
Warning: Do not inject intravascularly or intradermally. 
Opozorilo: ne injicirajte intravaskularno ali intradermalno.
Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue. 
Znaki alergijske reakcije so lahko med drugim kožni osip, zasoplost in oteklost obraza ali jezika.
Since AFLUNOV is expected not to be used in an emergency situation, its administration during pregnancy might be deferred as a precautionary approach. 
Ker se ne pričakuje, da bi se cepivo AFLUNOV uporabljalo v nujnih situacijah, se lahko uporaba med nosečnostjo preloži kot previdnostni ukrep.
Packs of 1 or 10 pre-filled syringes. 
Pakiranja po 1 ali 10 napolnjenih injekcijskih brizg.
Healthy N=62 
Zdravi N = 62
Post-marketing spontaneously reported adverse events and an interventional study do not suggest direct or indirect harmful effects of Focetria exposure on pregnancy. 
Na podlagi neželenih učinkov, o katerih so spontano poročali po pridobitvi dovoljenja za promet, in intervencijske študije se ne predvideva neposrednih ali posrednih škodljivih učinkov izpostavljenosti cepivu Focetria na nosečnost.
Healthy N=57 
Zdravi N = 57
What AFLUNOV is and what it is used for 
Kaj je cepivo AFLUNOV in za kaj ga uporabljamo
Anti-HA antibody (SRH) 
Protitelo proti HA (SRH)
Study V87_25 
Študija V87_25
Study V87_26 
Študija V87_26
Persistence of antibodies after primary vaccination in this population was assessed by hemagglutination inhibition (HI), SRH, and MN assays. 
Obstojnost protiteles po primarnem cepljenju v tej populaciji je bila ocenjena s testi zaviranja hemaglutinacije (HI), SRH in MN.
The incidence of adverse reactions has been evaluated in seven clinical trials in healthy subjects involving over 4300 adults and elderly receiving AFLUNOV (at least 7.5 µg HA, adjuvanted). 
Pogostnost neželenih učinkov so ocenili v sedmih kliničnih preskušanjih pri zdravih osebah, ki so zajela čez 4.300 odraslih in starejših oseb, ki so prejele cepivo AFLUNOV (vsaj 7,5 µg HA, z adjuvansom).
*actual age range of population enrolled 
*dejanski razpon starosti vključene populacije
It allows continued monitoring of the benefit/risk balance of the medicinal product. 
Omogoča namreč stalno spremljanje razmerja med koristmi in tveganji cepiva.
• Anaphylaxis (severe allergic reactions). 
• anafilaksa (hude alergijske reakcije).
87% of animals challenged with virus heterologous to the vaccine strain after 2 doses of vaccine were protected, and a single dose of heterologous vaccine protected 56% of the animals. 
87 % živali, provociranih z virusom, heterolognim na cepilni sev, je bilo zaščitenih po 2 odmerkih cepiva, en odmerek heterolognega cepiva pa je zaščitil 56 % živali.
However, in immunocompromised subjects 18 through 60 years of age, slightly higher rates of nausea (13.0%) were reported. 
Vendar pa so pri osebah z oslabljenim imunskim sistemom, starih od 18 let do vključno 60 let, poročali o rahlo višjih stopnjah navzee (13,0 %).
• in the presence of immune deficiencies AFLUNOV may be administered but a protective immune response may not be elicited. 
• v prisotnosti imunske pomanjkljivosti se cepivo AFLUNOV lahko daje, vendar ni nujno, da bo dosežen zaščitni imunski odziv.
Across studies V87_25 and V87_26, the safety of AFLUNOV in healthy adult and elderly subjects was consistent with existing safety data from previous clinical trials. 
V študijah V87_25 in V87_26 je bila varnost cepiva AFLUNOV pri zdravih odraslih in starejših osebah skladna z obstoječimi podatki o varnosti iz prejšnjih kliničnih preskušanj.
Excipient with known effect: The vaccine contains 1.899 milligrams of sodium and 0.081 milligrams of potassium per 0.5 ml dose. 
Pomožne snovi z znanim učinkom: Cepivo vsebuje 1,899 miligrama natrija in 0,081 miligrama kalija na odmerek 0,5 ml.
Do not throw any medicines via wastewater or household waste. 
Cepiva ne smete odvreči v odpadne vode ali med gospodinjske odpadke.
• Erythema multiforme (type of allergic skin reaction that occurs in response to medications, 
• Multiformni eritem (vrsta alergijske kožne reakcije, ki se pojavi v odziv na zdravila, okužbe ali bolezen).
In a similar study, intranasal challenge was delayed until approximately 4 months after the second dose of vaccine was administered. 
V podobni študiji so z intranazalno provokacijo počakali približno 4 mesece po drugem odmerku cepiva.